Annual losses at Biomet increase dramatically in a revised earnings release for the Warsaw, Ind.-based orthopedics maker.
Biomet amended its Q4 and annual earnings report to reflect a swing to red in Q4 and much deeper losses for the full year compared to earlier reports.
The Warsaw, Ind.-based orthopedics company posted losses of $221.2 million on $784 million in sales during the 3-month period ended May 31, 2013. An initial earnings report released in July had reported a $20.5 million profit for the quarter.
Tengion posts greater losses during the 2nd quarter as it develops its human organ transplant technology, but rakes in more than $30M in investments.
Tengion (NSDQ:TNGN) almost tripled its losses in the 2nd quarter, but raked in more than $30 million in investments for its human organ regeneration technology.
Medtronic shares come under pressure as investors react to mixed fiscal 1st-quarter results, with earnings in line with expectations but sales missing their target.
Investors pushed shares of Medtronic (NYSE:MDT) down this morning after the world's largest pure-play medical device company reported mixed results for its fiscal 1st quarter.
Fridley, Minn.-based Medtronic posted profits of $953 million, or 93¢ per share, on sales of $4.08 billion for the 3 months ended July 26. That's a 10.3% top-line gain on 1.9% sales growth.
Operating rofits rose 13% during the 2nd quarter for wound management company Kinetic Concepts Inc., despite a nearly 4% sales decline.
Operating profits rose 13.1% during the 2nd quarter for Kinetic Concepts Inc., despite a nearly 4% sales decline for the wound management company.
San Antonio, Texas-based KCI reported operating profits of $110.8 million on sales of $317.8 million for the 3 months ended June 30, according to a regulatory filing.
Syneron Medical's 2nd-quarter earnings meet Wall Street's expectations, but sales fall short, sending shares down on The Street.
Syneron Medical Ltd. (NSDQ:ELOS) stumbled during the 2nd quarter, posting earnings that were even with Wall Street's forecast but just missing sales expectations, sending share prices down this week.
A more than $1 million charge related to the loss of a lawsuit filed by former general counsel Leonard Keen forces Bovie Medical into 2nd-quarter losses.
Bovie Medical (NYSE:BVX) put some red ink in its ledger for the 2nd quarter, largely due to a more than $1 million charge stemming from a legal loss to its former top lawyer.
Baxano fails to meet Wall Streets expectations during its 2nd quarter of 2013, during which the company reinvented itself as Baxano Surgical.